Buyer landscape
Likely buyers · Biotech in France.
Prepared 2026-08-28 with GP Intel · deterministic scoring, published weights: gp-intel.com/methodology/league-tables
How companies like this sold · 392 verified exits: 35% to sponsors, 60% to corporates and platforms, 4% via IPO, 1% other routes. Route shift since 2020: sponsors 31% (was 42%), corporates and platforms 65% (was 50%), IPO 2% (was 8%).
The list: 25 Tier 1 · 0 Tier 2 of 120 matched buyers, including 6 geographic expansion candidates without a local platform yet. A first round of the Tier 1 names plus the expansion buyers covers the demonstrated demand.
Financial buyers · 23
Tier 1 · Very High · score 70+
1. Bpifrance Investissement SponsorVery High90
10 platform investments in Healthcare · 89 in France · 35 deals 2024–26
AUM €57.3B · Bpifrance Amorçage Industriel · 2023 vintage · deploying · check €1-8M
Accelerating: 30 deals in the last 2 years vs 4.5/yr before.
Backed Adcendo, 2026 · Biotech, Denmark
2. ArchiMed SponsorVery High86
56 platform investments in Healthcare · 13 in France · 18 deals 2024–26
AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M
18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.
Backed ExcellGene, 2025 · Biotech, Switzerland
3. Archimedes Partners SponsorVery High86
53 platform investments in Healthcare · 12 in France · 21 deals 2024–26
AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M
18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.
Backed ExcellGene, 2025 · Biotech, Switzerland
4. ARCHIMED and Institut Mérieux SponsorVery High86
54 platform investments in Healthcare · 13 in France · 19 deals 2024–26
AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M
18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.
Backed ExcellGene, 2025 · Biotech, Switzerland
5. ArchiMed and Tethys Invest SponsorVery High86
54 platform investments in Healthcare · 13 in France · 18 deals 2024–26
AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M
18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.
Backed ExcellGene, 2025 · Biotech, Switzerland
6. Turenne Groupe SponsorVery High84
55 platform investments in Healthcare · 311 in France · 34 deals 2024–26
AUM €2.0B · Capital Sante 3 · 2025 vintage · deploying · check €3-21M
20 platform investments since the 2025 vintage · early in deployment vs its usual 80 per fund.
Backed Mablink, 2021 · Biotech, France
7. Audacia SponsorVery High84
9 platform investments in Healthcare · 109 in France · 27 deals 2024–26
AUM €2.8B · Audacia Capital Développement IV · 2023 vintage · deploying · check €4-30M
45 platform investments since the 2023 vintage · largely deployed vs its usual 12 per fund.
Backed Biomemory, 2025 · Biotech, France
8. Ring Capital SponsorVery High84
10 platform investments in Healthcare · 52 in France · 32 deals 2024–26
AUM €470M · Ring Altitude II · 2025 vintage · deploying · check €4-33M
17 platform investments since the 2025 vintage · largely deployed vs its usual 13 per fund.
Backed Exapto, 2024 · Biotech, France
9. Merieux Equity Partners / Vitruvian Partners SponsorVery High83
57 platform investments in Healthcare · 33 in France · 6 deals 2024–26
AUM €1.6B · Mérieux Participations 5 · 2026 vintage · deploying · check €7-50M
2 platform investments since the 2026 vintage · early in deployment vs its usual 8 per fund.
Backed Ona Therapeutics, 2026 · Biotech, Spain
10. Irdi Capital-Investissement SponsorVery High82
25 platform investments in Healthcare · 131 in France · 33 deals 2024–26
AUM €550M · IRDI Impulsion · 2021 vintage · partially deployed · check €2-15M
76 platform investments since the 2021 vintage · largely deployed vs its usual 26 per fund.
Backed bYoRNA, 2025 · Biotech, France
11. Idia SponsorVery High81
12 platform investments in Healthcare · 126 in France · 27 deals 2024–26
AUM €2.4B · Crédit Agricole Assurances Avenir et Territoires · 2026 vintage · deploying · check €2-15M
5 platform investments since the 2026 vintage · early in deployment vs its usual 25 per fund.
Backed Lagarrigue, 2026 · Healthcare, France
12. Finorpa Gestion SponsorVery High81
8 platform investments in Healthcare · 85 in France · 27 deals 2024–26
Hauts-de-France Avenir TPE PME · 2026 vintage · deploying
8 platform investments since the 2026 vintage · early in deployment vs its usual 28 per fund.
Backed Genoskin, 2024 · Biotech, France
13. UI Investissement SponsorVery High81
14 platform investments in Healthcare · 41 in France · 11 deals 2024–26
AUM €1.7B · Cap Autrement · 2023 vintage · deploying
13 platform investments since the 2023 vintage · largely deployed vs its usual 10 per fund.
Backed Brenus Pharma, 2024 · Biotech, France
14. UI Investissement + Bpifrance SponsorVery High81
14 platform investments in Healthcare · 39 in France · 11 deals 2024–26
AUM €1.7B · Cap Autrement · 2023 vintage · deploying
13 platform investments since the 2023 vintage · largely deployed vs its usual 10 per fund.
Backed Brenus Pharma, 2024 · Biotech, France
15. UI Investissement + GENEO Capital Entrepreneur + Management SponsorVery High81
14 platform investments in Healthcare · 39 in France · 11 deals 2024–26
AUM €1.7B · Cap Autrement · 2023 vintage · deploying
13 platform investments since the 2023 vintage · largely deployed vs its usual 10 per fund.
Backed Brenus Pharma, 2024 · Biotech, France
16. UI Investissement and Esfin Gestion SponsorVery High81
14 platform investments in Healthcare · 39 in France · 10 deals 2024–26
AUM €1.7B · Cap Autrement · 2023 vintage · deploying
13 platform investments since the 2023 vintage · largely deployed vs its usual 10 per fund.
Backed Brenus Pharma, 2024 · Biotech, France
17. UI Investissement, Esfin Gestion and Unexo SponsorVery High81
14 platform investments in Healthcare · 39 in France · 10 deals 2024–26
AUM €1.7B · Cap Autrement · 2023 vintage · deploying
13 platform investments since the 2023 vintage · largely deployed vs its usual 10 per fund.
Backed Brenus Pharma, 2024 · Biotech, France
19. IK Partners SponsorVery High80
34 platform investments in Healthcare · 82 in France · 52 deals 2024–26
AUM €13.8B · IK Partnership Fund III · 2025 vintage · deploying · check €10-75M
18 platform investments since the 2025 vintage · largely deployed vs its usual 13 per fund.
Bought Biobank from Bpifrance Investissement, 2024 · Biotech, France
20. Capital Grand Est SponsorVery High80
23 platform investments in Healthcare · 63 in France · 11 deals 2024–26
AUM €228M · ReBest · 2023 vintage · deploying · check €1-6M
13 platform investments since the 2023 vintage · largely deployed vs its usual 13 per fund.
Backed Elkedonia · Biotech, France
21. Charterhouse Capital Partners SponsorVery High80
11 platform investments in Healthcare · 26 in France · 10 deals 2024–26
AUM €7.0B · Charterhouse Capital Partners XI · 2023 vintage · deploying · check €28-210M
10 platform investments since the 2023 vintage · mid-deployment vs its usual 14 per fund.
Backed Animalcare Group, 2026 · Healthcare, UK
22. Lauxera Capital Partners SponsorVery High80
16 platform investments in Healthcare · 4 in France · 6 deals 2024–26
AUM €780M · Lauxera Growth II · 2025 vintage · deploying · check €10-78M
3 platform investments since the 2025 vintage · early in deployment vs its usual 8 per fund.
Backed GenePlanet, 2026 · Biotech, Slovenia
24. Bridgepoint SponsorVery High79
34 platform investments in Healthcare · 47 in France · 43 deals 2024–26
AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M
4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.
Bought {my}dentist (formerly IDH) from Palamon Capital Partners, 2025 · Healthcare, UK
25. Bridgepoint Development Capital SponsorVery High79
31 platform investments in Healthcare · 41 in France · 36 deals 2024–26
AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M
4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.
Backed {my}dentist (formerly IDH), 2025 · Healthcare, UK
Strategic buyers · 2
Tier 1 · Very High · score 70+
18. Gilead Sciences CorporateVery High81
6 acquisitions in Healthcare · 1 in France · 4 deals 2024–26
Accelerating: 4 deals in the last 2 years vs 0.3/yr before.
Bought Tubulis from Athos, 2026 · Biotech, Germany
23. Ipsen CorporateVery High80
8 acquisitions in Healthcare · 6 in France · 8 deals 2024–26
Active in France since 2025.
Bought Memo Therapeutics from Ysios Capital Partners, 2026 · Biotech, CH
Scores and facts derive from verified deal records only; sample floors and thresholds are published on the methodology page. Figures marked with a tilde are bands, not disclosures.